Table 3 Angiographic characteristics of the two groups
From: Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon
CSFP group (n = 89) | Control group (n = 167) | p value | |
|---|---|---|---|
TIMI frame count | < 0.001 | ||
LAD (corrected) | 43.2 ± 24.8 | 19.7 ± 1.0 | |
LCX | 29.8 ± 10.1 | 18.8 ± 2.2 | |
RCA | 27.9 ± 8.8 | 17.2 ± 2.2 | |
mean TFC | 33.6 ± 9.4 | 18.6 ± 1.6 | |
Distribution of CSFP among major coronary arteries | |||
LAD, n (%) | 47 (52.8) | ||
LCX, n (%) | 54 (60.7) | ||
RCA, n (%) | 61 (68.5) | ||
Number of coronary arteries involved | |||
1, n (%) | 37 (41.6) | ||
2, n (%) | 31 (34.8) | ||
3, n (%) | 21 (23.6) | ||
Average number of coronary arteries with CSFP | 1.82 ± 0.79 | ||